OPKO Health Shares Outstanding 2010-2023 | OPK
OPKO Health shares outstanding from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| OPKO Health Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 752 |
| 2022 | 719 |
| 2021 | 648 |
| 2020 | 641 |
| 2019 | 595 |
| 2018 | 563 |
| 2017 | 559 |
| 2016 | 556 |
| 2015 | 488 |
| 2014 | 422 |
| 2013 | 355 |
| 2012 | 296 |
| 2011 | 281 |
| 2010 | 255 |
| 2009 | 233 |
| OPKO Health Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-12-31 | 752 |
| 2023-09-30 | 752 |
| 2023-06-30 | 752 |
| 2023-03-31 | 752 |
| 2022-12-31 | 719 |
| 2022-09-30 | 750 |
| 2022-06-30 | 713 |
| 2022-03-31 | 660 |
| 2021-12-31 | 648 |
| 2021-09-30 | 652 |
| 2021-06-30 | 647 |
| 2021-03-31 | 641 |
| 2020-12-31 | 641 |
| 2020-09-30 | 641 |
| 2020-06-30 | 641 |
| 2020-03-31 | 641 |
| 2019-12-31 | 595 |
| 2019-09-30 | 586 |
| 2019-06-30 | 586 |
| 2019-03-31 | 586 |
| 2018-12-31 | 563 |
| 2018-09-30 | 560 |
| 2018-06-30 | 560 |
| 2018-03-31 | 559 |
| 2017-12-31 | 559 |
| 2017-09-30 | 559 |
| 2017-06-30 | 564 |
| 2017-03-31 | 558 |
| 2016-12-31 | 556 |
| 2016-09-30 | 552 |
| 2016-06-30 | 557 |
| 2016-03-31 | 546 |
| 2015-12-31 | 488 |
| 2015-09-30 | 516 |
| 2015-06-30 | 462 |
| 2015-03-31 | 446 |
| 2014-12-31 | 422 |
| 2014-09-30 | 428 |
| 2014-06-30 | 413 |
| 2014-03-31 | 413 |
| 2013-12-31 | 355 |
| 2013-09-30 | 361 |
| 2013-06-30 | 337 |
| 2013-03-31 | 313 |
| 2012-12-31 | 296 |
| 2012-09-30 | 298 |
| 2012-06-30 | 298 |
| 2012-03-31 | 298 |
| 2011-12-31 | 281 |
| 2011-09-30 | 286 |
| 2011-06-30 | 285 |
| 2011-03-31 | 261 |
| 2010-12-31 | 255 |
| 2010-09-30 | 255 |
| 2010-06-30 | 255 |
| 2010-03-31 | 254 |
| 2009-12-31 | 233 |
| 2009-09-30 | 253 |
| 2009-06-30 | 226 |
| 2009-03-31 | 200 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.857B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $206.706B | 25.14 |
| Intuitive Surgical (ISRG) | United States | $132.078B | 79.62 |
| Edwards Lifesciences (EW) | United States | $52.037B | 34.44 |
| DexCom (DXCM) | United States | $51.775B | 88.94 |
| IQVIA Holdings (IQV) | United States | $41.231B | 24.45 |
| IDEXX Laboratories (IDXX) | United States | $39.682B | 47.45 |
| Alcon (ALC) | Switzerland | $38.694B | 28.53 |
| STERIS (STE) | Ireland | $19.843B | 23.49 |
| Hologic (HOLX) | United States | $17.628B | 19.46 |
| Waters (WAT) | United States | $17.451B | 25.04 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.168B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.248B | 84.63 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.379B | 14.05 |
| Sysmex ADR (SSMXY) | Japan | $9.881B | 30.99 |
| Teleflex (TFX) | United States | $9.768B | 15.34 |
| Penumbra (PEN) | United States | $7.812B | 96.57 |
| Masimo (MASI) | United States | $7.192B | 40.33 |
| Globus Medical (GMED) | United States | $6.870B | 21.78 |
| Glaukos (GKOS) | United States | $4.774B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.948B | 25.23 |
| TransMedics (TMDX) | United States | $2.854B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.847B | 18.78 |
| PROCEPT BioRobotics (PRCT) | United States | $2.603B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.599B | 17.83 |
| Integra LifeSciences Holdings (IART) | United States | $2.486B | 10.20 |
| Nihon Kohden (NHNKY) | Japan | $2.315B | 19.58 |
| Inari Medical (NARI) | United States | $2.240B | 386.40 |
| Tandem Diabetes Care (TNDM) | United States | $1.997B | 0.00 |
| RxSight (RXST) | United States | $1.914B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.703B | 0.00 |
| Veracyte (VCYT) | United States | $1.441B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.864B | 15.98 |
| Artivion (AORT) | United States | $0.833B | 96.24 |
| Paragon 28 (FNA) | United States | $0.800B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.701B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.696B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.682B | 0.00 |
| SiBone (SIBN) | United States | $0.628B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.537B | 18.25 |
| IRadimed (IRMD) | United States | $0.511B | 29.68 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.487B | 0.00 |
| Nevro (NVRO) | United States | $0.452B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.406B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.391B | 0.00 |
| NeuroPace (NPCE) | United States | $0.368B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.336B | 11.31 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| AxoGen (AXGN) | United States | $0.286B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.265B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.260B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.245B | 0.00 |
| Accuray (ARAY) | United States | $0.219B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.185B | 0.00 |
| 908 Devices (MASS) | United States | $0.184B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.179B | 9.64 |
| Atossa Genetics (ATOS) | United States | $0.178B | 0.00 |
| Inogen (INGN) | United States | $0.165B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.146B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.119B | 0.00 |
| Neuronetics (STIM) | United States | $0.115B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.100B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.094B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.090B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Vasomedical (VASO) | United States | $0.056B | 9.99 |
| Autonomix Medical (AMIX) | United States | $0.054B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 108.33 |
| InspireMD (NSPR) | Israel | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.049B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.044B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
| LENSAR (LNSR) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.016B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.016B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |